June 2025
1. DE SMIT NS, de Lange ME, Boomsma MF, Huirne JAF, et al
   Current treatment for symptomatic uterine fibroids: available evidence and therapeutic dilemmas.
   Lancet. 2025 Jun 19:S0140-6736(25)00728-7. doi: 10.1016/S0140-6736(25)00728.
   

   >> Share

   
   August 2024
2. RYDELIUS J, Hognert H, Kopp-Kallner H, Brandell K, et al
   First dose of misoprostol administration at home or in hospital for medical abortion between 12-22 gestational weeks in Sweden (PRIMA): a multicentre, open-label, randomised controlled trial.
   Lancet. 2024;404:864-873.
   

   >> Share

   
   August 2023
3. CAHILL EP
   Adding a COX-2 inhibitor improves efficacy of emergency contraception.
   Lancet. 2023 Aug 16:S0140-6736(23)01612-4. doi: 10.1016/S0140-6736(23)01612.
   

   >> Share

   
   
4. LI RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, et al
   Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial.
   Lancet. 2023 Aug 16:S0140-6736(23)01240-0. doi: 10.1016/S0140-6736(23)01240.
   

   >> Share

   
   June 2023
5. MARSTON C, Tabot M
   How can we put rights at the core of global family planning?
   Lancet. 2023;401:2096-2098.
   

   >> Share

   
   May 2023
6. MCCURRY J
   Japan approves abortion pill.
   Lancet. 2023;401:1558.
   

   >> Share

   
   April 2023
7. JAFFE S
   Drug developers caution against US mifepristone ban.
   Lancet. 2023;401:1325-1326.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share